



Objective: The objective of the present study was to examine the association of glucose 
intolerance and type-2 diabetes mellitus with the -174 G > C and -308 G > A allelic varia-
tions of IL-6 and TNF-α, respectively, through anthropometric measurements and age 
strata. Methods: This is a cross-sectional study using data from 285 community dwell-
ing elderly women who underwent physical, biochemical, and genetic examinations. 
Results: Genotype-unadjusted analysis revealed that the risk of glucose intolerance and 
diabetes in elderly women with elevated BMI was 1.71 and 2.82 times higher, respec-
tively, whereas age and conicity index did not show predictive value. Prevalence ratios 
for glucose intolerance and diabetes across allelic variants of IL-6 and TNF-α did not 
associate IL-6 with unbalanced glucose levels, despite adjustment for BMI, age, and co-
nicity index. Conversely, carriers of the TNF-α A allele were 2.06 and 5.58 times more 
likely to exhibit glucose intolerance and diabetes, respectively, compared to GG homozy-
gotes. Conclusion: Our results suggest that bearing the A allele of the -308 G > A poly-
morphism of TNF-α predisposes to anthropometric measure-sensitive impaired glucose 
metabolism in older women.
Keywords: Elderly health; insulin resistance; cytokines; polymorphism, genetic; anthro-
pometry.
Study conducted at Universidade 





CNPq (protocol 484318/2006-3 
and 402699/2007-6) and FAPDF 




Programa de Pós-Graduação 
em Ciências Médicas
Faculdade de Medicina, 
Universidade de Brasília – UNB
Campus Universitário 
Darcy Ribeiro, Asa Norte,
Brasília – DF, Brazil
CEP: 70910-900
Phone: 55 (61) 3307 2520
nobrega@pq.cnpq.br 
otavionobrega@unb.br
Conflict of interest: None.
©2011 Elsevier Editora Ltda.
Risk of glycemic disorder in elderly women adjusted by anthropometric 
parameters and cytokine genotypes
APARECIDO PIMENTEL FERREIRA1, CRISTIANE BATISTI FERREIRA2, VINÍCIUS CAROLINO SOUZA3, AUDREY CECÍLIA TONET FURIOSO4,  
JULIANA OLIVEIRA TOLEDO5, CLAYTON FRANCO MORAES6, CLÁUDIO CÓRDOVA7, OTÁVIO TOLÊDO NÓBREGA8
1 PhD in Physical Education; Professor and Coordinator of the Interdisciplinary Research Nucleus of ICESP/Faculdades Promove; Professor and Leader of the Exercise Physiology and 
Health Study Group, Universidade Paulista (UNIP), DF, Brazil
2 BSc in Pharmacy; Researcher of the Interdisciplinary Research Nucleus of ICESP/Faculdades Promove de Brasília, Brasília, DF, Brazil 
3 BSc in Biology; MSc Student, Postgraduate Program in Health Sciences, UnB; Technician of the Immunogentology Laboratory of Universidade Católica de Brasília (UCB), Brasília, 
DF, Brazil
4 MSc in Gerontology; Postgraduate Program in Gerontology,  Universidade Católica de Brasília; Postgraduate Program in Medical Sciences, Universidade de Brasília (UnB), Brasília, DF, Brazil
5 MSc in Gerontology; Postgraduate Program in Gerontology, UCB; PhD Student, Postgraduate Program in Health Sciences, UnB; Professor, Faculdade Lourdes Santana – LS, Brasília, 
DF, Brazil
6 MSc in Gerontology; Postgraduate Program in Gerontology, UCB, Brasília, DF, Brazil
7 PhD in Physical Education; Postgraduate Program in Physical Education and Health of UCB, Brasília, DF, Brazil
8 PhD in Molecular Pathology; Professor of the Postgraduate Program in Health Sciences of UnB, Brasília, DF, Brazil
Este é um artigo Open Access sob a
licença de CC BY-NC-ND
APARECIDO PIMENTEL FERREIRA ET AL.
554 Rev Assoc Med Bras 2011; 57(5):553-557
INTRODUCTION
The increase in the number of people over 60 years of 
age is a visible phenomenon in almost every country. In 
Brazil, the last census indicates the possibility that the 
number of elderly people is above 30 million1, represent-
ing almost 13% of the population2. It is known that aging 
exposes people to higher prevalence of chronic diseases, 
such as type 2 diabetes mellitus, which aαects 17.4% of 
the population from 60 to 69 years of age, according to the 
census of 1986 and 19883. Its high incidence rate, add-
ed to the diαerent clinical complications resulting from 
macro- and microvascular disruption, make this disease 
a public health problem.
Among anthropometric variables that commonly 
predict endocrine-metabolic disorders, the body mass 
index (BMI) and conicity index (C index) should be em-
phasized4,5. Despite the imminent relationship between 
age and deregulation of glycemic levels, primary and 
contributing causes for changes in this aspect of human 
metabolism are still debatable. Etiologic possibilities cur-
rently discussed involve aspects related to lifestyle due to 
inadequate diet and physical inactivity, factors closely re-
lated to obesity6, as well as endocrine deαciency second-
ary to exhaustion of α cells and/or idiopathic humoral 
interferences in glucose uptake by cells7,8, with possible 
allele-speciαc contributions from important inαamma-
tory mediators9-12.
The objective of the present study was to analyze the 
association between BMI, C index, and age with glucose 
intolerance phenotypes and type 2 diabetes mellitus in el-
derly women, considering the inαuence of classical allelic 
variations of IL-6 and TNF-α genes.
METHODS
This is an analytical transversal study with data from 285 
elderly females (α 60 years) recruited consecutively from 
the community to participate in the study conducted 
from 2005 to 2008, whose protocol was approved by the 
institutional ethics on research committee. Every partici-
pant signed an informed consent. Participants were not 
on nutritional follow-up nor did they practice regular ex-
ercises before laboratorial tests and anthropometric mea-
surements were performed.
PHYSICAL AND BIOCHEMICAL EXAMS
Patients were wearing light clothes during the physical 
exam. Height was measured using a manual stadiometer 
placed on the wall, with patients barefoot and erect on a 
αat and rigid surface with arms along their body. Body 
mass index (BMI) was obtained by dividing body mass 
(in kg) by the square height (in m2), while the C index 
was estimated to be 9.17 times the ratio between waist 
circumference (m) and the square root of the ratio be-
tween body mass (kg) and height (m).
Biochemical evaluation consisted of 12-hour fast-
ing glucose serum levels using Roche® (USA) reagents. 
The reference value (α 126 mg/dL) recommended by the 
American Diabetes Association13 or current use of oral 
hypoglycemic agent or insulin was used to classify type 2 
diabetes. Glucose intolerance was deαned as glucose levels 
α 100 mg.dL-1 or presence of diabetes, according to recom-
mendations of the International Diabetes Federation14,15.
LABORATORIAL ANALYSIS
To determine IL-6 alleles, a region of 628 bp of the gene 
containing a single nucleotide polymorphism (SNP) 
-174 G > C of the promoter region (rs1800795) was am-
pliαed using a pair of oligonucleotides: 5’-GAA CAC 
AGA AGA ACT CAG ATG ACT GG-3’ (forward) and 
5’- AGG AGT TCA TAG CTG GGC TCC TGG AG-3’ 
(reverse). Variability of the TNF-α gene was investigated 
by amplifying a fragment of 327  bp containing the -308   
SNP G > A (rs1800629) of the promoter region of the 
gene, using oligonucleotides A (5’-CCT CAA GCC TGC 
CAC CAA GC-3’; forward) and B (5’-TCC TCC CTG 
CTC CGA TTC CG-3’; reverse). Each individual reaction 
was composed of: 100 ng DNA. 10 mM Tris-HCL pH 9.2; 
25 mM KCL; 1.5 mM MgCl2; 0.2 mM dNTP; 20 pmol of 
each oligonucleotide; 0.5 μg ovalbumin; and 1 unit of Taq 
DNA polymerase (Phoneutria, Minas Gerais, Brazil) in a 
αnal volume of 50 μL. Aαer a hot start at 80°C for 1 minute 
and a initial denaturation step at 94°C for 2 minutes, each 
ampliαcation cycle consisted of 40 seconds at 94°C, 45 s at 
64°C, and 50 s at 72°C repeated 36 times and αnalized by 
an extension step at 72°C for 5 minutes. Each PCR prod-
uct was sequenced in the ABI PRISM 3130 DNA analyzer 
system (Applied Biosystems, Foster City, USA) using the 
oligonucleotide 5’-GCC TCA GAG ACA TCT CCA GTC 
C-3’, for IL-6 products, and oligonucleotide A, for TNF-α 
products. Each sequence obtained was examined using the 
biostatistics soαware package Staden (MRC, Cambridge, 
United Kingdom) and conαrmed by visual inspection.
STATISTICAL ANALYSIS
Data on sample characterization are presented as mean 
and standard deviation or relative frequency. General 
prevalence of glucose intolerance and diabetes was cal-
culated for each stratum (age α 65 years and > 65 years, 
BMI  α  27  kg/m2 and >  27  kg/m2, conicity index α  1.25 
and > 1.25), as well as the prevalence of IL-6 and TNF-α 
genotypes in each stratum. The Chi-square test was used 
to identify frequency diαerences among strata. Prevalence 
ratios (PR) of glucose intolerance and diabetes were calcu-
lated as dichotomies in elected strata (lower stratum = 0 
and upper stratum  =  1). Additionally, dummy variables 
were created for comparison among strata, assuming the 
lower stratum (= 0) as the reference, of each study variable 
for IL-6 and TNF polymorphisms, for IL-6 (CG = 0 and 
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GC and CC = 1), for TNF (GA and AA = 0 and GG = 1) 
and, when the genes were analyzed together (GG, for 
IL-6, and GA and AA, for TNF = 0 and the remaining com-
binations = 1). Dierences were analyzed by the Mantel-
Hanzel test. The condence interval of 95% was used. Data 
were analyzed by the statistical soware Stata, version 7.0.
RESULTS
Table 1 shows the characteristics of the study population, 
including age proαle, anthropometric data, and represen-
tative variables of glycemic metabolism in elderly women 
who participated in the study.
Considering the mean values of age, BMI, and 
C index, we decided to use dichotomization of the sam-
ple (age  α  65  years or >  65  years, BMI  α  27  kg/m2 or 
> 27 kg/m2, conicity index α 1.25 or > 1.25) in subsequent 
analysis. Thus, statistics comparing the prevalence of glu-
cose intolerance and type 2 diabetes among groups are pre-
sented in Table 2. In this analysis, age and C index were not 
predictive of glucose intolerance or diabetes. However, the 
group of elderly women with BMI > 27 kg/m2 was 1.71 and 
2.82 times more likely to present glucose intolerance 
and diabetes, respectively.
When prevalence ratios of glucose intolerance and 
diabetes were analyzed, according to variants of IL-6 
and TNF-α genes, adjusted for BMI, age, and C index, it 
was noticed that neither IL-6 genotype was a risk or pro-
tection factor for glycemic deregulation (Table 3). On the 
other hand, carriers of the TNF-α allele A were 2.06 and 
5.58 times more likely to have glucose intolerance and dia-
betes, respectively, when compared to GG homozygous in 
the strata of people with BMI α 27 kg/m2 (Table 4).
DISCUSSION
In the present study, glucose intolerance and diabetes 
were observed in 27.6% and 16.8% of all cases investi-
gated, respectively. The prevalence of glucose intolerance 
and diabetes did not diαer among the diαerent strata for 
age, C index, or IL-6 or TNF-α genotypes. However, it dif-
fered between BMI strata (p = 0.031), with glucose intol-
erance and diabetes signiαcantly higher in the group with 
Variable Mean ± Standard deviation
n (elderly) 285
Age (years) 67.8 ± 6.1
Weight (kg) 93.9 ± 10.8
Height (m) 1.52 ± 0.10
BMI (kg/m²) 27.5 ± 4.3
C index (m) 1.29 ± 0.10
Glycemia (mg/dL) 106.3 ± 29.4
Glucose intolerance (%) 27.6
Diabetes (%) 16.8
BMI, body mass index; C index, conicity index.
Table 1 – Characteristics of the study population






BMI (> 27 kg/m²) 1.71 (1.14-2.56) * 2.82 (1.50-5.30) *
Age (> 65 years) 1.05 (0.70-1.59) 1.30 (0.71-2.37)
C index (> 1,25) 1.26 (0.84-1.89) 1.03 (0.61-1.76)
BMI, body mass index; C index, conicity index; CI, condence 
interval; * p < 0.05 compared to the group with BMI  27 kg/m².
Table 2 – Prevalence ratio for glucose intolerance and type 
2 diabetes among elderly women stratified by BMI, age, 
and CoI





BMI  27 kg/m² 1.17 (0.59-2.34) 1.33 (0.43-4.13)
BMI > 27 kg/m² 0.71 (0.43-1.19) 0.64 (0.32-1.24)
Age  65 years 0.64 (0.29-1.39) 0.49 (0.14-1.66)
Age > 65 years 0.93 (0.58-1.50) 0.86 (0.45-1.65)
C index  1.25 0.86 (0.42-1.80) 0.97 (0.40-2.38)
C index > 1.25 0.81 (0.49-1.31) 0.62 (0.29-1.31)
BMI, body mass index; C index, conicity index; CI, condence 
interval; differences were not observed when GG homozygous 
were compared to carriers of the C allele.
Table 3 – Prevalence ratio for glucose intolerance and type 2 
diabetes among elderly women dichotomized by -174 G > C 
IL-6 polymorphism in each age and anthropometric groups





BMI  27 kg/m² 2.06 (1.03-4.17)* 5.58 (1.86-16.74)*
BMI > 27 kg/m² 0.72 (0.37-1.42) 0.57 (0.22-1.49)
Age  65 years 1.98 (0.96-4.07) 1.87 (0.58-6.00)
Age > 65 years 0.84 (0.45-1.55) 1.05 (0.50-2.22)
C index  1.25 0.62 (0.21-1.85) 0.59 (0.15-2.36)
C index > 1.25 1.37 (0.82-2.29) 1.70 (0.84-3.46)
BMI, body mass index; C index, conicity index; CI, condence 
interval; * p < 0.05 whenever carriers of allele A are compared 
to genotype GG.
Table 4 – Prevalence ratio for glucose intolerance and 
type 2 diabetes among elderly women dichotomized by 
the -308 TNF-_ G > A polymorphism in each age and an-
thropometric groups
APARECIDO PIMENTEL FERREIRA ET AL.
556 Rev Assoc Med Bras 2011; 57(5):553-557
BMI higher than 27 kg/m2. Subsequent analyses were ad-
justed to cancel the inuence of the BMI, being observed 
that prevalence of glucose intolerance or diabetes did not 
show signicant variation according to IL-6 genotypic 
category. Similar analysis performed for TNF-α genotypic 
categories showed dierent results, in which carriers of 
the TNF-α A allele had more chances of presenting glu-
cose intolerance and diabetes. However, this nding was 
observed only in the stratum below the threshold strati-
cation established for the study (BMI < 27 kg/m2). This 
result was most likely due to the fact that excessive adi-
posity superseded the eects of an isolated gene on the 
pathophysiology of insulin resistance, masking the con-
tribution of the TNF-α A allele on glycemic disorders, 
making it evident only in strata of body composition with 
a tendency to eutrophy16.
However, one cannot deny the hypothesis of the 
TNF-α A allele being an explanation in cases of insulin 
resistance and diabetes. To this end, González-Sanches et 
al.17, in a population-based epidemiologic study, analyzed 
the interaction among both genes, some cardiovascular 
risk factors, and biochemical disorders in more than 800 
Caucasian patients ages 35 to 74 years. They observed that 
the -308 G > A SNP of the TNF-α gene can be related to 
a higher prevalence of insulin resistance and incidence of 
type 2 diabetes mellitus, regardless of insulin resistance, 
BMI, and waist-hip relationship.
Nicaud et al.12 investigated the role of -308 G > A SNP 
of the TNF-α gene in insulin resistance and they observed 
the association between the A allele with type 2 diabetes. 
Studies have suggested that the TNF-α -308A/G gene SNP 
is related with serum levels of the respective mediator be-
cause the A allele seems to predispose higher transcrip-
tional levels of the gene, producing increased serum con-
centrations compared to the allele G18,19. According to the 
evidence that dierent cardiovascular risk factors (includ-
ing hypertension, dyslipidemias, and insulin resistance) 
are intensied by circulating levels of TNF-α, regardless 
of gender and age stratum20-23, allele A is more common 
among patients with metabolic disorders common in the 
elderly12,16,24.
It has been reported in the literature that TNF-α has 
an important role in insulin resistance, interfering with 
the insulin signaling pathway12. The mechanism of induc-
tion of insulin resistance by this cytokine is probably due 
to induction of phosphorylation of the insulin receptor 
substrate 1 (IRS-1), decreasing its a nity for the insulin 
receptor, attenuating signal transmission by compromis-
ing phosphorylation of the receptor to tyrosine25-27. The 
impossibility to determine circulating levels of the inam-
matory mediators investigated represents a limitation of 
the present study. Besides, performing this study with el-
derly women implies that caution should be taken when 
extrapolating the results to other gender or age group.
Summarizing, non-adjusted analysis for genotype 
showed that elderly women with elevated BMI had 1.71 
and 2.82 times greater risk of developing glucose intol-
erance and diabetes, respectively, while age group and 
C index did not show any predictive value. Apart from this 
association, our results suggest that the presence of the 
A allele of -308 G > A TNF-α gene predisposes to the devel-
opment of glycemic disorders sensitive to the context, since 
glucose intolerance and type 2 diabetes phenotypes are 
not inuenced by any of the genotypes being investigated 
among individuals with BMI compatible with obesity.
ACKNOWLEDGEMENTS
Our acknowledgements to the Hospital da Universidade 
Católica de Brasília and Laboratório SABIN for providing 
conditions to perform this study, and to professor Soraia 
Figueiredo Carmo for the orthographic review.
REFERENCES
1. Instituto Brasileiro de Geograóa e Estatística. 2009. [cited 16 Feb 
2009]. Available at: http://www.ibge.gov.br/home/estatistica/popu-
lacao/projecao_da_populacao/piramide/piramide.shtm.
2. Nobrega OT, Faleiros VP, Telles JL. Gerontology in the develop-
ing Brazil: achievements and challenges in public policies. Geriatr 
Gerontol Int 2009;9:135-9.
3. Mathias TA, Jorge MH. Diabetes mellitus na população idosa em 
municípios da Região Sul do Brasil: um estudo da mortalidade e 
morbidade hospitalar. Arq Bras Endocrinol Metabol 2004;48:505-12.
4. Ferreira AP, Nobrega Ode T, Franca NM. Association of body mass 
index and insulin resistance with metabolic syndrome in Brazilian 
children. Arq Bras Cardiol 2009;93:147-53.
5. Pitanga FJG, Lessa I. Sensibilidade e especiócidade do índice de co-
nicidade como discriminador do risco coronariano de adultos em 
Salvador, Brasil. Rev Bras Epidemiol 2004;7:259-69.
6. Hawley JA, Houmard JA. Introduction-preventing insulin resis-
tance through exercise: a cellular approach. Med Sci Sports Exerc 
2004;36:1187-90.
7. Ivy JL. Muscle insulin resistance amended with exercise training: 
role of GLUT4 expression. Med Sci Sports Exerc 2004;36:1207-11.
8. Dela F, Ploug T, Handberg A, Petersen LN, Larser JJ, Mikines KJ et 
al. Physical training increases muscle GLUT4 protein and mRNA in 
patients with NIDDM. Diabetes 1994;43:862-5.
9. Beránek M, Kanková K, Benes P, Izakovicováet-Hollá L, Znojil V, 
Hájek D et al. Polymorphism R25P in the gene encoding trans-
forming growth factor-beta (TGF-beta1) is a newly identióed 
risk factor for proliferative diabetic retinopathy. Am J Med Genet 
2002;109:278-83.
10. Huth C, Heid IM, Vollmert C, Gieger D, Grallert H, Wolford JK 
et al. IL6 gene promoter polymorphisms and type 2 diabetes: joint 
analysis of individual participants data from 21 studies. Diabetes 
2006;55:2915-21.
11. Tonet AC, Karnikowski M, Moraes CF, Gomes L, Karnikowski MG, 
Córdova C et al. Association between the -174 G/C promoter poly-
morphism of the interleukin-6 gene and cardiovascular disease risk 
factors in Brazilian older women. Braz J Med Biol Res 2008;41:47-53.
12. Nicaud V, Raoux S, Poirier O, Cambien F, O´Reilly DS, Tiret L. The 
TNF alpha/G-308A polymorphism inóuences insulin sensitivity in 
oóspring of patients with coronary heart disease: the European Ath-
erosclerosis Research Study II. Atherosclerosis 2002;161:317-25.
13. Diagnosis and classiócation of diabetes mellitus. Diabetes Care 
2004;27(Suppl 1):S5-S10.
14. Hanley AJ, Karter AJ, Williams K, Festa A, D´Agostino RB Jr, Wa-
genlnech T et al. Prediction of type 2 diabetes mellitus with alterna-
tive deónitions of the metabolic syndrome: the Insulin Resistance 
Atherosclerosis Study. Circulation 2005;112:3713-21.
RISK OF GLYCEMIC DISORDER IN ELDERLY WOMEN ADJUSTED BY ANTHROPOMETRIC PARAMETERS AND CYTOKINE GENOTYPES
557Rev Assoc Med Bras 2011; 57(5):553-557
15. International Diabetes Federation. 2005. [cited 2009 Feb 18]. Avail-
able from: http://www.idf.org/metabolic_syndrome.
16. Pihlajamaki J, Ylinen M, Karhapaa P, Vauhkonen I, Laakso M. The 
eect of the -308A allele of the TNF-alpha gene on insulin action is 
dependent on obesity. Obes Res 2003;11:912-7.
17. González-Sánchez JL, Martínez-Calatrava MJ, Martínez-Larrad 
MT, Zabena C, Fernández-Pérez C, Laakso M et al. Interaction of 
the -308G/A promoter polymorphism of the tumor necrosis factor-
alpha gene with single-nucleotide polymorphism 45 of the adipo-
nectin gene: eect on serum adiponectin concentration in Spanish 
population. Clin Chem 2006;52:97-103.
18. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Du GW. Ef-
fects of a polymorphism in the human tumor necrosis factor alpha 
promoter on transcriptional activation. Proc Natl Acad Sci USA 
1997;94:3195-9.
19. Fernandez-Real JM. Genetic predispositions to low-grade inamma-
tion and type 2 diabetes. Diabetes Technol Ther 2006;8:55-66.
20. Bennet AM, van Maarle MC, Hallqvist J, Morgenstern R, Frostegard 
J, Wiman B et al. Association of TNF-alpha serum levels and TNFA 
promoter polymorphisms with risk of myocardial infarction. Ath-
erosclerosis 2006;187:408-14.
21. Skoog T, Dichtl W, Boquist S, Skoglund-Andersson C, Karpe F, Tang 
R et al. Plasma tumour necrosis factor-alpha and early carotid athero-
sclerosis in healthy middle-aged men. Eur Heart J 2002;23:376-83.
22. Lechleitner M, Herold M, Dzien-Bischinger C, Hoppichler F, Dzien 
A. Tumour necrosis factor-alpha plasma levels in elderly patients 
with Type 2 diabetes mellitus-observations over 2 years. Diabet Med 
2002;19:949-53.
23. Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma interleukin-6, 
tumour necrosis factor alpha and blood cytokine production in type 
2 diabetes. Life Sci 2000;67:291-300.
24. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A et 
al. Polymorphisms of the tumour necrosis factor-alpha gene, coro-
nary heart disease and obesity. Eur J Clin Invest 1998;28:59-66.
25. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression 
of tumor necrosis factor-alpha: direct role in obesity-linked insulin 
resistance. Science 1993;259:87-91.
26. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegel-
man BM. IRS-1-mediated inhibition of insulin receptor tyrosine ki-
nase activity in TNF-alpha- and obesity-induced insulin resistance. 
Science 1996;271:665-8.
27. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A et al. 
Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at 
inhibitory Ser307 via distinct pathways. J Clin Invest 2001;107:181-9.
